Lin, Hsiao-Hui <br/><br/>
Inhibition of the Wnt/β-catenin signaling pathway improves the anti-tumor effects of sorafenib against hepatocellular carcinoma.  [electronic resource] 

 -  Cancer letters  10 2016 
 - 58-66 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1872-7980 
<br/><br/><label>Standard No.: </label>10.1016/j.canlet.2016.07.013  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Apoptosis--drug effects<br/>Apoptosis Regulatory Proteins--metabolism<br/>Bridged Bicyclo Compounds, Heterocyclic--pharmacology<br/>Carcinoma, Hepatocellular--genetics<br/>Cell Proliferation--drug effects<br/>Dose-Response Relationship, Drug<br/>Gene Expression Regulation, Neoplastic<br/>Hep G2 Cells<br/>Humans<br/>Liver Neoplasms--genetics<br/>Male<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Myeloid Cell Leukemia Sequence 1 Protein--metabolism<br/>Niacinamide--analogs & derivatives<br/>Phenylurea Compounds--pharmacology<br/>Protein Kinase Inhibitors--pharmacology<br/>Pyrimidinones--pharmacology<br/>RNA Interference<br/>RNAi Therapeutics<br/>Sorafenib<br/>Transfection<br/>Wnt Signaling Pathway--drug effects<br/>Xenograft Model Antitumor Assays<br/>beta Catenin--antagonists & inhibitors